By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MaxCyte, Inc. 

22 Firstfield Road, Suite 250

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-944-1700 Fax: 301-944-1703



Company News
MaxCyte, Inc. And Partners To Present Data At PEGS Europe 11/2/2015 12:59:32 PM
MaxCyte, Inc. To Present At 2015 Bioprocess International Conference 10/26/2015 11:14:35 AM
MaxCyte, Inc. Appoints Spinco Biotech Pvt Ltd. As Distributor In India For The MaxCyte STX And MaxCyte VLX 10/20/2015 12:45:48 PM
MaxCyte, Inc.To Present Novel Approach To Car-T For Treatment Of Solid Tumors At Biochemical Society In London 10/13/2015 12:03:31 PM
MaxCyte, Inc. To Present At 2015 Immuno-Oncology Conference 9/30/2015 10:49:54 AM
MaxCyte, Inc. To Present New Data On Expression And Functionality Of Bispecific Antibodies Produced Via Transient Transfection 9/22/2015 10:06:05 AM
MaxCyte, Inc. And Johns Hopkins University Announce Strategic Immuno-Oncology Collaboration To Advance CAR T-Cell Therapies 4/21/2015 11:45:46 AM
MaxCyte, Inc. To Present At 3rd Annual Regen Med Investor Day 3/24/2015 2:16:26 PM
MaxCyte, Inc. Release: Accelerating Product Development: From Transient Transfection To Stable Pools And Stable Clones 5/14/2014 9:15:57 AM
MaxCyte, Inc. Introduces Rapid, Automated, Scalable Flow Electroporation-Based Technology For Vaccine Development 3/20/2014 10:11:22 AM